A national study investigates the glycemic and renal effects of SGLT2 inhibitors in patients with monogenic diabetes. The findings contribute to understanding treatment efficacy in this rare patient population.
glycemic and renal effects of sglt2 inhibitors in monogenic diabetes a real world national study
Original title: “Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real-World National Study.”